The regulatory approval represents the completion of the Cytogam technology tran...
The merger and associated financing are scheduled to be completed by the third q...
The approval allows KALYDECO to be used in infants who have at least one mutatio...
Breyanzi’s approval is based on the data obtained from the Phase III TRANSFORM t...
The regulatory decision is supported by data from Phase III clinical trials and ...
A gathering of experts in CAR-T cancer therapy at #STAT breakthrough express opt...
At the #STATBreakthrough Summit, researchers made scientific pitches as ambitiou...
Studies in human brain tissue, neural stem cells, and mice have linked the herpe...
“There’s very few physicians who understand what technology can do, and definite...
“Thirty years after the HIV epidemic, why is there still a time lag of years to ...
After early-stage breast cancer, women can pause taking endocrine therapy to bec...
"Probably any words I use to describe my emotions at seeing this data will under...
At six years old, Emily Whitehead became the first child to receive CAR-T cancer...
Two new studies, while both observational, suggest that the longstanding practic...
After receiving 38,000 public comments, the DEA announces a delay in new rules t...
The FDA has approved the first-ever vaccine for respiratory syncytial virus, or ...
